StockData
NeOnc Technologies Holdings, Inc. logo

NeOnc Technologies Holdings, Inc. (NTHI) stock

NTHINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 0/30
$3.48−0.68 (-16.35%)

Close on Nov 19, 2026Market cap $90.26MP/E –Yield –

NeOnc Technologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

NeOnc Technologies's operating income for the twelve months ending Sep 30, 2026 was -$40.66M. For fiscal 2025 it was -$58.24M.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$58.24M–
FY2024Dec 31, 2024-$7.14M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$5.83M–
Q2 FY2026Jun 30, 2026-$14.07M–
Q1 FY2026Mar 31, 2026-$7.06M–
Q4 FY2025Dec 31, 2025-$13.70M–
Q3 FY2025Sep 30, 2025-$6.93M–
Q2 FY2025Jun 30, 2025-$5.71M–
Q1 FY2025Mar 31, 2025-$31.90M–
Q4 FY2024Dec 31, 2024-$2.11M–
Q3 FY2024Sep 30, 2024-$2.20M–
Q2 FY2024Jun 30, 2024-$1.28M–
Q1 FY2024Mar 31, 2024-$1.55M–

More NeOnc Technologies figures

See a number that looks wrong?